Magic Wallstent Endoprothesis
FDA premarket approval P980009 · Stent, Coronary
PMA numberP980009
Approval
- Applicant
- Boston Scientific Scimed, Inc.
- Received
- April 1, 1998
- Decision date
- September 29, 1998 (APWD)
- Supplements
- 13, latest October 31, 2005
- Product code
- MAF – Stent, Coronary
Approval order statement
Approval for the Magic WALLSTENT(R) Endoprosthesis. This device is indicated for improving coronary luminal diameter in the following: 1) patients with symptomatic ischemic disease due to discreter de novo lesions in native coronary arteries (length <35mm) with a reference vessel diameter of 3.0 to 5.5mm; 2) treatment of abrupt or threatened closure in patients with failed interventional therapy in lesions with reference diameters in the range of 3.0 to 5.5mm.